Longevity science is advancing rapidly. At the same time, the supplement and optimization marketis saturated with noise, exaggerated claims, and premature conclusions.For professionals and health-conscious individuals, distinguishing robust clinical evidence fromcommercial hype has become increasingly difficult.Zerivax exists to reduce that uncertainty.
Structured evaluation of clinical evidence.
Clear distinction between validated interventions and exploratory research.
Applied interpretation for real-world decision-making.
Independent, advertising-free editorial model.
Documented references.
Defined evaluation structure.
Explicit distinction between strong and emerging evidence.
Institutional editorial signature.
No sensationalism.
Zerivax Editorial is led by a physician specialist in Internal Medicine with advanced training in Clinical Nutrition and Health Economics. Multidisciplinary collaboration ensures analytical rigorwhile maintaining clarity and accessibility
Zerivax Longevity Brief is an independent publication. It does not receive advertising or commercial sponsorship. In the future, the platform may develop initiatives related to products evaluated underdefined methodological standards, while maintaining editorial independence as a guiding principle